XML 93 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Highlights (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Sep. 21, 2021
Sep. 20, 2021
Investment Company, Financial Highlights [Roll Forward]                            
Net asset value, beginning balance (in dollars per share) $ 15.31 $ 15.11 $ 15.98 [1] $ 16.26 $ 15.89 $ 16.20 $ 16.34 [1] $ 15.98 [1] $ 16.34 [1] $ 15.50 [1] $ 16.80 $ 17.38    
Net investment income (loss) (in dollars per share)               1.92 [2] 1.56 [2] 1.31 [2] 1.39 1.54    
Net realized (loss) gain and net change in unrealized (depreciation) appreciation on investments and (loss) gain on foreign currency (in dollars per share)               (0.18) (0.68) 0.79 (1.57) (0.63)    
Total net increase (decrease) (in dollars per share)               1.74 0.88 2.10 (0.18) 0.91    
Shareholder distributions:                            
Distributions declared to stockholders from net investment income (in dollars per share)               (1.61) (1.44) (1.26) (1.12) (1.49)    
Capital share transactions:                            
Issuance of common stock above net asset value (in dollars per share)               0 0 0 0 0    
Repurchases of common stock below net asset value (in dollars per share)               0.12 0.20 0 0 0    
Net increase in net assets resulting from capital share transactions (in dollars per share) 15.80 15.31 15.11 15.98 16.26 15.89 16.20 0.12 0.20 0 0 0    
Net asset value, ending balance (in dollars per share) $ 15.80 $ 15.31 $ 15.11 $ 15.98 [1] $ 16.26 $ 15.89 $ 16.20 $ 16.23 [1] $ 15.98 [1] $ 16.34 [1] $ 15.50 [1] $ 16.80    
Shares outstanding at end of period (in shares)       55,299,484 [1]       54,184,636 [1] 55,299,484 [1] 56,958,440 [1] 56,646,867 56,690,578 56,958,440 113,916,869
Total investment return-net value               17.00% 10.44% 14.43% (0.94%) 5.55%    
Total investment return-market asset value               34.33% (14.87%) 3.87% 0.00% 0.00%    
Net assets at beginning of period     $ 883,634 [3]       $ 930,512 $ 883,634 [3] $ 930,512 $ 878,256 $ 952,563 $ 979,271    
Net assets at end of period       $ 883,634 [3]       879,563 [4] 883,634 [3] 930,512 878,256 952,563    
Average net assets for the period       $ 917,781       $ 864,886 $ 917,781 $ 918,824 $ 875,846 $ 967,323    
Ratio/Supplemental data:                            
Ratio of net investment income to average net assets               12.14% 9.61% 8.09% 8.99% 9.03%    
Ratio of gross operating expenses to average net assets               16.88% 11.63% 9.04% 9.72% 11.76%    
Ratio of net operating expenses to average net assets               16.88% 11.63% 9.04% 9.72% 11.76%    
Portfolio turnover               17.43% 26.81% 52.04% 22.99% 31.59%    
Total amount of senior securities outstanding               $ 1,092,344 $ 957,500 $ 830,000 $ 725,000 $ 841,042    
Asset coverage ratio       192.00%       181.00% 192.00% 212.00% 221.00% 213.00%    
Issuance of shares, per share (in dollars per share)               $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01    
Repurchase of shares, per share (in dollars per share)                   $ 0.01 $ 0.01 $ 0.01    
Number of shares (in shares)               1            
[1] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share for 2021 reflect the reverse stock split on a retroactive basis.
[2] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The weighted average shares used in the computation of the net increase (decrease) in net assets per share resulting from operations and net investment income per share for 2021 reflect the reverse stock split on a retroactive basis.
[3] Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.
[4] Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.